A federal judge is as circumspect about experts’ conclusions that women’s use of OTC acetaminophen during pregnancy is unsafe as she was of the argument that federal preemption precludes complaints alleging regulatorily compliant labeling causes a failure to warn about potential risks.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?